| Adelina Merry Tan Uypeckcuat, | |
|
10050 Woodland Dr, Lenexa, KS 66220-3802 | |
| (913) 397-0906 | |
| Not Available |
| Full Name | Adelina Merry Tan Uypeckcuat |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10050 Woodland Dr, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316652845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-15405 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Adelina Merry Tan Uypeckcuat, 10050 Woodland Dr, Lenexa, KS 66220-3802 Ph: (913) 397-0906 | Adelina Merry Tan Uypeckcuat, 10050 Woodland Dr, Lenexa, KS 66220-3802 Ph: (913) 397-0906 |
News Archive
Infinity Pharmaceuticals, Inc. today announced promising preliminary results from a Phase 1 study of IPI-926, its novel, oral small molecule that targets the Hedgehog pathway.
A report released on Sunday by a task force of the Association of American Medical Colleges that recommends new restrictions on what physicians, staff members and students at U.S. medical schools can accept from drug companies and medical device makers is "encouraging," but it "flinched" on some important issues, a New York Times editorial states (New York Times, 4/29).
House Majority Leader Eric Cantor, R-Va., appears to be trying to push President Barack Obama in one direction and Minority Leader Nancy Pelosi, D-Calif., is standing firm on Obama's left. Meanwhile, Senate Majority Leader Harry Reid, D-Nev., is taking a go-big-or-go-home position on the need to reach a "grand deal" on entitlement cuts and revenue raisers.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).
Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts. Their findings were published online Feb. 23 in Nature Nanotechnology.
› Verified 3 days ago
Jacob Thomas Stolz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15100 W 87th Street Pkwy, Lenexa, KS 66219 Phone: 913-438-5172 | |
Katy Dolinar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13400 W 87th Street Pkwy, Lenexa, KS 66215 Phone: 913-438-6651 | |
Christopher Shane Slifer, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11131 W 79th St, Lenexa, KS 66214 Phone: 913-234-4664 Fax: 913-234-4665 | |
Jill Ann Ottinger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11131 W 79th St, Lenexa, KS 66214 Phone: 913-234-4664 | |
Jerald E. Bowmer, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17301 W 84th Ter, Lenexa, KS 66219 Phone: 913-530-1493 Fax: 913-599-5435 | |
Ms. Elaine Carol Clancy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11162 Renner Blvd, Lenexa, KS 66219 Phone: 800-360-0520 | |
Jonathan Fernandez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10050 Woodland Dr, Lenexa, KS 66220 Phone: 913-397-0906 Fax: 913-397-0332 |